title: IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5.
authors.forename: Nabil
authors.initials: N
authors.lastname: Antaki
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Bibert
authors.forename: Kamel
authors.initials: K
authors.lastname: Kebbewar
authors.forename: Fouad
authors.initials: F
authors.lastname: Asaad
authors.forename: Osama
authors.initials: O
authors.lastname: Baroudi
authors.forename: Sawsan
authors.initials: S
authors.lastname: Alideeb
authors.forename: Milad
authors.initials: M
authors.lastname: Hadad
authors.forename: Dirar
authors.initials: D
authors.lastname: Abboud
authors.forename: Houda
authors.initials: H
authors.lastname: Sabah
authors.forename: Pierre-Yves
authors.initials: PY
authors.lastname: Bochud
authors.forename: Francesco
authors.initials: F
authors.lastname: Negro
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D016174:Hepacivirus / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007378:Interleukins / Q000235:genetics*; D008297:Male; D020641:Polymorphism, Single Nucleotide
chemical_list: D000998:Antiviral Agents; D007378:Interleukins